Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor site revision labels updated: added Revision: v3.3.2 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:45:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:55:50.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-11-03T20:58:01.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:11:12.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:03.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-14T18:59:35.000Z thumbnail image

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.